Track Astellas Pharma Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Astellas Pharma Inc. 4503.T · Stock Open Astellas Pharma Inc. in new tab

2387.00 JPY
P/E
14.71
EPS
162.32
Yield
3.42%
Safety Score
92
P/B
2.20
ROE
21.30
Beta
0.08
Target Price
2476.43 JPY
Loading chart...
Key Metrics
Earnings dateNov. 4, 2026
P/E14.71
EPS162.32
Book Value1083.48
Price to Book2.20
Debt/Equity30.34
% Insiders0.113%
Growth
Revenue Growth0.27%
Earnings Growth1.07%
Estimates
Forward P/E31.50
Forward EPS75.77
Target Mean Price2476.43
Dividend
Dividend Yield3.42%
Annual dividends78.00 JPY
Ex-Div. DateMarch 30, 2027
Payout38.30%
5y avg Yield3.50%

DCF Valuation

Tweak assumptions to recompute fair value for Astellas Pharma Inc. (4503.T)
Currency: JPY
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Astellas Pharma Inc. Logo Astellas Pharma Inc. Analysis (4503.T)

Japan Health Care Official Website Stock

Is Astellas Pharma Inc. a good investment? Astellas Pharma Inc. (4503.T) is currently trading at 2387.00 JPY. Market analysts have a consensus price target of 2476.43 JPY. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 14.71. This relatively low multiple may signal that Astellas Pharma Inc. is undervalued compared to historical market norms.

Earnings Schedule: Astellas Pharma Inc. is expected to release its next earnings report on Nov. 4, 2026. The market consensus estimate for Forward EPS is 75.77.

For income investors, Astellas Pharma Inc. pays a dividend yield of 3.42%. With a payout ratio of 38%, the dividend appears sustainable.

Investor FAQ

Does Astellas Pharma Inc. pay a dividend?

Yes, it pays an annual dividend of 78.00 JPY (3.42% yield).

What asset class is Astellas Pharma Inc.?

Astellas Pharma Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 4, 2026. The company currently has a trailing EPS of 162.32.

Company Profile

Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric adenocarcinoma and esophagogastric junction adenocarcinoma; and PADCEV, a treatment for patients with metastatic urothelial carcinoma. It also provides VEOZAH, a treatment for vasomotor symptoms associated with menopause; IZERVAY, a treatment for age-related macular degeneration with geographic atrophy; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf, an immunosuppressant. It offers its products to oncology, ophthalmology, urology, immunology, and women's health areas. The company was formerly known as Yamanouchi Pharmaceutical Co. Ltd. and changed its name to Astellas Pharma Inc. in April 2005. Astellas Pharma Inc. was founded in 1923 and is headquartered in Chuo, Japan.

Exchange Ticker
JPX (Japan) 4503.T
FRA (Germany) YPH.F
STU (Germany) YPH.SG
PNK (United States) ALPMF
Trades
Dividend Yield
3.42%
5y avg 3.50%
Annual Dividends
78.00JPY
Next Ex. Div Date
March 30, 2027
Payout Ratio
38.30%
Dividend History paid per year (JPY)
Historical Dividends
Year Total Dividends
2027
84.92 JPY
June 1, 2027 (estimated) 44.9196
March 30, 2027 40.0000
2026
79.00 JPY
Sept. 29, 2026 40.0000
June 3, 2026 39.0000
2025
76.00 JPY
Dec. 1, 2025 39.0000
June 3, 2025 37.0000
2024
72.00 JPY
Dec. 2, 2024 37.0000
June 3, 2024 35.0000
2023
65.00 JPY
Dec. 1, 2023 35.0000
June 1, 2023 30.0000
2022
55.00 JPY
Dec. 1, 2022 30.0000
June 1, 2022 25.0000
2021
46.00 JPY
Dec. 1, 2021 25.0000
June 1, 2021 21.0000
2020
41.00 JPY
Dec. 1, 2020 21.0000
June 1, 2020 20.0000
2019
39.00 JPY
Dec. 2, 2019 20.0000
June 19, 2019 19.0000
2018
37.00 JPY
Dec. 3, 2018 19.0000
June 18, 2018 18.0000
2017
35.00 JPY
Dec. 1, 2017 18.0000
June 20, 2017 17.0000
2016
33.00 JPY
Sept. 28, 2016 17.0000
March 29, 2016 16.0000
2015
32.00 JPY
Sept. 28, 2015 16.0000
March 27, 2015 16.0000
2014
84.00 JPY
Sept. 26, 2014 14.0000
March 27, 2014 70.0000
2013
130.00 JPY
Sept. 26, 2013 65.0000
March 27, 2013 65.0000
2012
130.00 JPY
Sept. 26, 2012 65.0000
March 28, 2012 65.0000
2011
125.00 JPY
Sept. 28, 2011 60.0000
March 29, 2011 65.0000
2010
125.00 JPY
Sept. 28, 2010 60.0000
March 29, 2010 65.0000
2009
120.00 JPY
Sept. 25, 2009 60.0000
March 26, 2009 60.0000
2008
120.00 JPY
Sept. 25, 2008 60.0000
March 26, 2008 60.0000
2007
90.00 JPY
Sept. 25, 2007 50.0000
March 27, 2007 40.0000
2006
80.00 JPY
Sept. 26, 2006 40.0000
March 28, 2006 40.0000
2005
46.00 JPY
Sept. 27, 2005 30.0000
March 28, 2005 16.0000
2004
31.00 JPY
Sept. 27, 2004 15.0000
March 26, 2004 16.0000
2003
25.00 JPY
Sept. 25, 2003 15.0000
March 26, 2003 10.0000
2002
20.00 JPY
Sept. 25, 2002 10.0000
March 26, 2002 10.0000
2001
25.00 JPY
Sept. 25, 2001 10.0000
March 27, 2001 15.0000
2000
25.00 JPY
Sept. 26, 2000 10.0000
March 28, 2000 15.0000
Upcoming Dividends
Name Payment Date Status Amount
Astellas Pharma Inc. Mar 30, 2027 Upcoming 40.0 JPY
Astellas Pharma Inc. Sep 29, 2026 Upcoming 40.0 JPY
Astellas Pharma Inc. Jun 03, 2026 39.0 JPY
Astellas Pharma Inc. Dec 01, 2025 39.0 JPY
Stock Splits
Split Date Split Ratio to 1
March 27, 2014 5:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion